FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22428511000001108: Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Jun 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
74126201000001114 Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
74126301000001117 Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Is a Lansoprazole 15mg orodispersible gastro-resistant tablets 28 tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has AMP Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start